At the 19th Conference on Retroviruses and Opportunistic Infections in Seattle, Dr. Helen Ayles presented some key results on behalf of the ZAMSTAR team from the first randomized trial of a combined HIV and TB intervention strategy to demonstrate a reduction in population prevalence of tuberculosis. The study, conducted in 24 communities in Zambia and […]
Treating patients co-infected with HIV and tuberculosis (TB) can be tricky – as rifampin, a key sterilizing drug in TB regimens – can reduce concentrations of antiretrovirals administered at the same time, as well as other drug-drug complications. Early efforts to combat this phenomenon have unearthed a potential treatment candidate – an increased dose of […]
A study presented at the 19th Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle Thursday demonstrated the first empirical evidence of a population-level reduction in risk of acquiring HIV infection in communities with antiretroviral therapy (ART) coverage of all HIV-infected people (greater than 20 percent). Dr. Frank Tanser of the Africa Center for Health […]
At a plenary session Thursday at the 19th Conference on Retroviruses and Opportunistic Infections, Christopher Murray, MD, PhD, presented preliminary data from the 2010 revision of the Global Burden of Disease. This effort, funded by the Bill & Melinda Gates Foundation, is aimed at analyzing global health trends to quantify the comparative magnitude of health […]
Investigators at the 19th Conference on Retroviruses and Opportunistic Infections Wednesday reviewed studies looking to improve linkage to care rates after HIV diagnosis in sub-Saharan Africa. Dr. Gabriel Chamie of the University of California at San Francisco discussed outcomes in a routine linkage-to-care strategy versus and an enhanced strategy for accelerated antiretroviral therapy (ART) start […]
Dr. Michael Saag presented data on behalf of the Center for Infectious Disease Research in Zambia (CIDRZ) about a randomized trial of routine versus discretionary viral load monitoring among adults starting antiretroviral (ART) in Zambia Wednesday at the 19th Conference on Retroviruses and Opportunistic Infections. In mid-2004 when ART was rolled out, the decision was […]
The following is a guest blog post by HIV Medicine Association Executive Director Andrea Weddle, who is live-blogging from the 19th Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle. Patient retention in HIV programs has remained stable in a number of resource-limited countries despite rapid patient caseload and program growth since 2003. According to […]
Data shows HIV investments in PEPFAR focus countries lowered mortality by 20 percent compared to non-focus countries Dr. Eran Bendavid of Stanford University set out to convince an audience at the 19th Conference of Retroviruses and Opportunistic Infections (CROI) Wednesday that assistance to Africa through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) program […]
The following is a guest blog post by HIV Medicine Association Executive Director Andrea Weddle, who is live blogging from the 19th Conference on Retroviruses and Opportunistic Infections in Seattle. HIV incidence among non-Muslim men has decreased with greater uptake of voluntary medical male circumcision (MMC) in Uganda, according to data presented Tuesday at CROI. […]
Dr. Dorothy Mbori-Ngacha from UNICEF presented a sobering picture of the potential to eliminate 90 percent of HIV infections among children by 2015—the goal established by UNAIDS and the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) program in June of 2011. She outlined the four pillars of the achieving that goal at the 19th […]
HIV
Leader Needed to Fight Another Pandemic: HIV – While the COVID-19 pandemic has disrupted HIV services worldwide, the office of U.S. Global AIDS Coordinator has remained […]
Tuberculosis
In the six weeks before South Africa responded its first diagnoses of COVID-19 with the start of physical distancing measures, more than 47,000 people on average […]
Research & Development
By Mitchell Warren, executive director, AVAC In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN […]
Policy
By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]